Vanguard Therapeutics' Grant

Vanguard Therapeutics raised a round of funding on February 15, 2014. Investors include Small Business Innovation Research Awards.

Vanguard Therapeutics is an early stage California company that is developing a disease changing, orally absorbable, cell adhesion-blocking drug for prophylactic therapy of sickle cell disease (SCD).…

Articles about Vanguard Therapeutics' Grant: